| |
| |
|
| Insider
Information: |
Alton Gregg H |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,846 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,709,345 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,846 |
|
|
| Total
Value |
$3,709,345 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-03-01 |
4 |
AS |
$77.64 |
$1,967,315 |
D/D |
(25,000) |
44,426 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-03-01 |
4 |
OE |
$40.56 |
$699,660 |
D/D |
17,250 |
69,426 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
19,151 |
63,577 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2019-02-06 |
4 |
D |
$68.75 |
$402,944 |
D/D |
(5,861) |
57,716 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Patient Officer |
• • – |
2019-02-15 |
4 |
A |
$57.45 |
$18,959 |
D/D |
330 |
58,046 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2022-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
700 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
3,800 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2011-03-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
10,020 |
40,157 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2011-03-15 |
4/A |
D |
$39.79 |
$186,058 |
D/D |
(4,676) |
35,481 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2013-01-30 |
5 |
A |
$0.00 |
$0 |
D/D |
21,332 |
56,270 |
0 |
- |
|
360 Records found
|
|
Page 15 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
